Morphology and other prognostic factors of hepatocellular carcinoma.

OBJECTIVE Hepatocellular carcinoma is a malignancy found worldwide that has typically poor prognosis despite treatment. Although several studies have dealt with prognostic factors, just a few detailed analyses of large series correlating the pathology of hepatocellular carcinoma with prognosis are available. The present study was undertaken to address this limitation. PATIENTS AND METHODS Our prior clinical study described 432 patients, but sufficient tissue was available for evaluation in only 299 patients. Of these, 224 samples contained primary hepatocellular carcinoma, while the remainder contained only metastatic tumor. Characteristics evaluated included degree of tumor differentiation, associated cirrhosis or hepatitis, presence of cytoplasmic inclusion bodies, and blood vessel invasion by the neoplasm. RESULTS Of the 224 patients, 71% were male, 65% white, and 73% over the age of 45 years. Ninety-one percent were from North America. A total of 42 patients were found to have cirrhosis. Thirty-five percent had cytoplasmic inclusion bodies, and 25% showed evidence of blood vessel invasion. Tumor response rates (tumor shrinkage) were low (8%) regardless of treatment. Presence of cytoplasmic eosinophilic inclusion bodies and blood vessel invasion were not associated with increased survival. Some histopathologies (pelioid, spindle cell, fibrolamellar) were associated with a better prognosis. Patients with a predominant trabecular pattern (43%) did particularly poorly. Although sex was significantly associated with survival using a univariate analysis, this effect disappeared in a multivariate Cox model that adjusted simultaneously for other factors. CONCLUSION This investigation suggests that histologic subtype and clinical features may provide useful prognostic information in hepatocellular carcinoma. Poorer survival was observed in males, older patients with poorly differentiated tumors, or when associated with cirrhosis. Age younger than 45 years was a good prognostic factor, and presence of cirrhosis had an adverse effect on survival.

[1]  M. Kojiro,et al.  Pathology of Hepatocellular Carcinoma , 2006 .

[2]  R. Jenkins,et al.  Hepatocellular carcinoma in the United States: Prognostic features, treatment outcome, and survival , 1996, Cancer.

[3]  A. Gasbarrini,et al.  Clinical and pathologic features of hepatocellular carcinoma in young and older italian patients , 1996, Cancer.

[4]  K. Ishak,et al.  Comparison of tumor pathology with duration of survival of north american patients with hepatocellular carcinoma , 1995, Cancer.

[5]  T. Kasai,et al.  Predictable factors for estimating prognosis of patients after resection of hepatocellular carcinoma , 1993, Cancer.

[6]  N. Nagasue,et al.  Liver Resection for Hepatocellular Carcinoma Results of 229 Consecutive Patients During 11 Years , 1993, Annals of surgery.

[7]  K. Okuda,et al.  Hepatocellular carcinoma: Recent progress , 1992, Hepatology.

[8]  P. Bedossa,et al.  Independent risk factors for hepatocellular carcinoma in french drinkers , 1991, Hepatology.

[9]  J. Bruix,et al.  Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patients , 1990, Hepatology.

[10]  R. Peters,et al.  Tumors of the Liver and Intrahepatic Bile Ducts , 1990 .

[11]  A. Cnaan,et al.  Prognostic factors for survival in hepatocellular carcinoma. , 1988, Cancer research.

[12]  V. Guinee,et al.  Factors affecting the prognosis of primary liver carcinoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[14]  C. Lai,et al.  Histologic prognostic indicators in hepatocellular carcinoma , 1979, Cancer.

[15]  K. Okuda,et al.  New trends in hepatocellular carcinoma , 1993, International journal of clinical & laboratory research.

[16]  C. Falkson,et al.  Current approaches in the management of patients with hepatocellular carcinoma. , 1992, Oncology research.

[17]  R. Purcell,et al.  Etiology, pathology, and treatment of hepatocellular carcinoma in North America , 1991 .

[18]  G. Chejfec,et al.  Antigenic markers of hepatocellular carcinoma , 1990, Cancer.

[19]  B. Conne,et al.  Histopathologic features of hepatocellular carcinoma in Zaire , 1990, Cancer.

[20]  E. ArévaloJiménez,et al.  Primary liver cancer , 1985 .

[21]  Y. Kondo Histologic features of hepatocellular carcinoma and allied disorders. , 1985, Pathology annual.